Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B
Animals
Antibodies, Monoclonal
/ chemistry
Camelids, New World
Cell Cycle
Cell Proliferation
HEK293 Cells
Humans
Immunoconjugates
/ chemistry
Immunotoxins
/ chemistry
Receptors, Cell Surface
/ chemistry
Saporins
/ chemistry
Single-Domain Antibodies
/ biosynthesis
Transcobalamins
/ metabolism
Vitamin B 12
/ metabolism
TCblR
crystal structure
drug-delivery
nanobody
transcobalamin
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
04
02
2022
received:
03
09
2021
accepted:
10
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
8
3
2022
Statut:
ppublish
Résumé
Cellular uptake of vitamin B
Identifiants
pubmed: 35218573
doi: 10.1096/fj.202101376RR
doi:
Substances chimiques
Antibodies, Monoclonal
0
Immunoconjugates
0
Immunotoxins
0
Receptors, Cell Surface
0
Single-Domain Antibodies
0
Transcobalamins
0
transcobalamin receptor
0
Saporins
EC 3.2.2.22
Vitamin B 12
P6YC3EG204
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e22222Informations de copyright
© 2022 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.
Références
Nielsen MJ, Rasmussen MR, Andersen CBF, Nexo E, Moestrup SK. Vitamin B-12 transport from food to the body's cells-a sophisticated, multistep pathway. Nat Rev Gastro Hepat. 2012;9:345-354.
Hall CA, Colligan PD, Begley JA. Cyclic activity of the receptors of cobalamin bound to transcobalamin II. J Cell Physiol. 1987;133:187-191.
Lindemans J, Kroes AC, van Geel J, van Kapel J, Schoester M, Abels J. Uptake of transcobalamin II-bound cobalamin by HL-60 cells: effects of differentiation induction. Exp Cell Res. 1989;184:449-460.
Amagasaki T, Green R, Jacobsen DW. Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells. Blood. 1990;76:1380-1386.
Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin. Blood. 2009;113:186-192.
Gick GG, Arora K, Sequeira JM, Nakayama Y, Lai SC, Quadros EV. Cellular uptake of vitamin B12: role and fate of TCblR/CD320, the transcobalamin receptor. Exp Cell Res. 2020;396:112256.
Waibel R, Treichler H, Schaefer NG, et al. New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Res. 2008;68:2904-2911.
Quadros EV, Nakayama Y, Sequeira JM. Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320. Mol Cancer Ther. 2010;9:3033-3040.
Quadros EV, Nakayama Y, Sequeira JM. Saporin conjugated monoclonal antibody to the transcobalamin receptor TCblR/320 is effective in targeting and destroying cancer cells. J Cancer Ther. 2013;4:1074-1081.
Clardy SM, Allis DG, Fairchild TJ, Doyle RP. Vitamin B-12 in drug delivery: breaking through the barriers to a B-12 bioconjugate pharmaceutical. Expert Opin Drug Del. 2011;8:127-140.
Muyldermans S. Nanobodies: natural single-domain antibodies. Annu Rev Biochem. 2013;82:775-797.
Wang Y, Fan Z, Shao L, et al. Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications. Int J Nanomedicine. 2016;11:3287-3303.
De Meyer T, Muyldermans S, Depicker A. Nanobody-based products as research and diagnostic tools. Trends Biotechnol. 2014;32:263-270.
Morrison C. Nanobody approval gives domain antibodies a boost. Nat Rev Drug Discov. 2019;18:485-487.
Scully M, Cataland SR, Peyvandi F, et al. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2019;380:335-346.
Alam A, Woo JS, Schmitz J, et al. Structural basis of transcobalamin recognition by human CD320 receptor. Nat Commun. 2016;7:12100.
Mireku SA, Sauer MM, Glockshuber R, Locher KP. Structural basis of nanobody-mediated blocking of BtuF, the cognate substrate-binding protein of the Escherichia coli vitamin B12 transporter BtuCD. Sci Rep. 2017;7:14296.
Pardon E, Laeremans T, Triest S, et al. A general protocol for the generation of nanobodies for structural biology. Nat Protoc. 2014;9:674-693.
Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun. 2010;1:100.
Jiang WX, Nakayama Y, Sequeira JM, Quadros EV. Mapping the functional domains of TCblR/CD320, the receptor for cellular uptake of transcobalamin-bound cobalamin. FASEB J. 2013;27:2988-2994.
Jiang W, Nakayama Y, Sequeira JM, Quadros EV. Characterizing monoclonal antibodies to antigenic domains of TCblR/CD320, the receptor for cellular uptake of transcobalamin-bound cobalamin. Drug Deliv. 2011;18:74-78.
Kabsch W. Xds. Acta Crystallogr D. 2010;66:125-132.
Mccoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr. 2007;40:658-674.
Rasmussen SGF, Choi HJ, Fung JJ, et al. Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature. 2011;469:175-180.
Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D. 2004;60:2126-2132.
Adams PD, Afonine PV, Bunkoczi G, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Cryst D. 2010;66:213-221.
DeLano WL. The PyMOL Molecular Graphics System (Version 2.0). Schrödinger, LLC; 2017.
Brinkley M. A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents. Bioconjug Chem. 1992;3:2-13.
Polito L, Bortolotti M, Mercatelli D, Battelli MG, Bolognesi A. Saporin-S6: a useful tool in cancer therapy. Toxins. 2013;5:1698-1722.
Martinez-Jothar L, Beztsinna N, van Nostrum CF, Hennink WE, Oliveira S. Selective cytotoxicity to HER2 positive breast cancer cells by Saporin-loaded nanobody-targeted polymeric nanoparticles in combination with photochemical internalization. Mol Pharm. 2019;16:1633-1647.
Chapman-Smith A, Cronan JE Jr. In vivo enzymatic protein biotinylation. Biomol Eng. 1999;16:119-125.
Wuerges J, Garau G, Geremia S, Fedosov SN, Petersen TE, Randaccio L. Structural basis for mammalian vitamin B12 transport by transcobalamin. Proc Natl Acad Sci USA. 2006;103:4386-4391.
Kishan KV, Newcomer ME, Rhodes TH, Guilliot SD. Effect of pH and salt bridges on structural assembly: molecular structures of the monomer and intertwined dimer of the Eps8 SH3 domain. Protein Sci. 2001;10:1046-1055.
Quadros EV, Lai SC, Nakayama Y, et al. Positive newborn screen for methylmalonic aciduria identifies the first mutation in TCblR/CD320, the gene for cellular uptake of transcobalamin-bound vitamin B-12. Hum Mutat. 2010;31:924-929.
Punjani A, Fleet DJ. 3D variability analysis: resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. J Struct Biol. 2021;213:107702.
Bloch JS, Mukherjee S, Kowal J, et al. Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins. Proc Natl Acad Sci. 2021;118(47):e2115435118.
Fan X, Wang J, Zhang X, et al. Single particle cryo-EM reconstruction of 52 kDa streptavidin at 3.2 Angstrom resolution. Nat Commun. 2019;10:2386.
Liu Y, Huynh DT, Yeates TO. A 3.8 A resolution cryo-EM structure of a small protein bound to an imaging scaffold. Nat Commun. 2019;10:1864.
Bloch JS, Pesciullesi G, Boilevin J, et al. Structure and mechanism of the ER-based glucosyltransferase ALG6. Nature. 2020;579:443-447.
Mohanty R, Chowdhury CR, Arega S, Sen P, Ganguly P, Ganguly N. CAR T cell therapy: a new era for cancer treatment (Review). Oncol Rep. 2019;42:2183-2195.
Vaneycken I, Devoogdt N, Van Gassen N, et al. Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer. FASEB J. 2011;25:2433-2446.